Advertisement

Topics

InteRNA Technologies BV Company Profile

19:36 EST 17th November 2017 | BioPortfolio

InteRNA Technologies B.V. actively explores and exploits opportunities to translate its unique collection of miRNAs and miRNA discovery and validation technologies into successful diagnostic, prognostic and therapeutic applications. The company's primary focus is to unravel the role of its proprietary miRNAs in cancer.


News Articles [200 Associated News Articles listed on BioPortfolio]

Hollaender® Manufacturing’s Interna-Rail® VUE Chosen to Adorn Main Lobby at ProNova Solutions

Hollaender Manufacturing, manufacturer of Interna-Rail® aluminum railing systems, was chosen by architect Christopher Rutledge, of Michael Brady Inc., to provide the railing system for ProNova So...

InteRNA Technologies BV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryInteRNA Technologies BV InteRNA is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical r...

Latest maintenance strategies in multiple myeloma

Professor McCarthy (Roswell Park Cancer Institute, New York, USA) and Professor Ruiz-Argüelles (Centro de Hematologia y Medicina Interna, Mexico) discuss the latest maintenance strategies in multiple...

Advanced Enzymes acquires evoxx

The industrial biotechnology company evoxx technologies GmbH has become a part of specialty biotech company Advanced Enzyme Technologies Limited. Both companies announced that they have entered into a...

Partnership agreement signed to combine epigenetics technologies

A partnership agreement has been entered into by Cambridge Epigenetix (CEGX) and NuGEN Technologies to cover the manufacture and integration of technologies for epigenetic research.

DBV Technologies: DBV Technologies Reports September 30, 2017 Cash Position

Press ReleaseMontrouge, France, October 31, 2017 DBV Technologies Reports September 30, 2017 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today a...

Agilent acquires Cobalt, expanding value for pharma and biopharma

Specialist in analytical laboratory technologies, Agilent Technologies, has acquired Cobalt Light Systems, which develops products and technologies for non-invasive, through-barrier chemical analysis ...

AMS Technologies Extends Design Services with Acquisition of Elforlight

Acquisition strengthens company’s competence and expertise for solving the most challenging photonics applications  AMS Technologies, Europe’s leading solution provider and distributo...

PubMed Articles [341 Associated PubMed Articles listed on BioPortfolio]

Establishment of an in vitro culture model of theca cells from hierarchical follicles in ducks.

Theca cells, including theca interna cells and theca externa cells, are vital components of ovarian follicles. The aim of this study is to identify a reliable method for the in vitro culture of theca ...

Disease Stabilization of DYT1-Positive Primary Generalized Dystonia With Deep Brain Stimulation of the Globus Pallidus Interna: A 15-yr Follow-up.

Primary generalized dystonia (PGD) is a genetic form of dystonia that frequently displays pharmacological resistance and progresses quickly after onset. Deep brain stimulation (DBS) has been used succ...

Transcriptomal profiling of bovine ovarian granulosa and theca interna cells in primary culture in comparison with their in vivo counterparts.

In vitro culture of ovarian granulosa cells and theca cells has been very important for our understanding of their function and regulation. One of the most eagerly sought attributes of cell culture is...

Angio-OCT de la zona avascular foveal en ojos con oclusión venosa de la retina.

Objetivo: El objetivo del estudio comprendía visualizar y cuantificar las alteraciones patológicas de la zona avascular foveal (ZAF) mediante angio-OCT en ojos con oclusión venosa de la retina (OVR...

Health technology assessments conducted in health care facilities: A strategic practice? Findings from a content analysis of HTA reports.

In this paper, we test the hypothesis that health technology assessment units located in hospitals tend to be more optimistic toward technologies that are currently in use in their organization than t...

Clinical Trials [330 Associated Clinical Trials listed on BioPortfolio]

Deep Brain Stimulation (DBS) of the Nucleus Basalis of Meynert (NbM) in Patients With Parkinson's Disease

The existing DBS setting in patients with DBS of the globus pallidus interna (GPi), which aims to treat motor symptoms by a high-frequency stimulation, will be temporarily reprogramed to s...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Companies [1229 Associated Companies listed on BioPortfolio]

InteRNA Genomics

InteRNA Genomics B.V., a subsidiary of InteRNA Technologies B.V. and based in Bilthoven, the Netherlands, offers services and software for processing, analyzing and presenting ultra-high-throughpu...

InteRNA Technologies BV

InteRNA Technologies B.V. actively explores and exploits opportunities to translate its unique collection of miRNAs and miRNA discovery and validation technologies into successful diagnostic, prog...

InteRNA Technologies B.V.

InteRNA Technologies B.V. actively explores and exploits opportunities to translate its unique collection of miRNAs and miRNA discovery and validation technologies into successful diagnostic, prog...

LVL Technologies, Inc.

LVL Technologies, Inc. was founded by Dr. Dustin Freckleton and Nithin Rajan with a mission of bringing the accuracy of medical device technologies to the consumer wearables marke...

CA Technologies

CA Technologies (NASDAQ: CA) is an IT management software and solutions company with expertise across all IT environments - from mainframe and distributed, to virtual and cloud. For additional inf...

More Information about "InteRNA Technologies BV" on BioPortfolio

We have published hundreds of InteRNA Technologies BV news stories on BioPortfolio along with dozens of InteRNA Technologies BV Clinical Trials and PubMed Articles about InteRNA Technologies BV for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InteRNA Technologies BV Companies in our database. You can also find out about relevant InteRNA Technologies BV Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record